$1.62
0.042.53%
近くで: Sep 25, 5:00 PM EST
$1.61
-0.01-0.62%
時間外: Sep 25, 7:56 PM EST
Benzinga
Benzinga
Benzinga
日曜日, 9 27
Pacific Biosciences of California Inc
PACBNASDAQ
Pacific Biosciences Earnings & Forecasts
Pacific Biosciences (PACB) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pacific Biosciences Guidance
Pacific Biosciences (PACB) は、8 5, 2026日にfiscal yearの2026に関するガイダンスを直近で発表しました。同社は当期の売上高を$155M - $165Mの範囲と予想しています。
以前のガイダンスと比較して、Pacific Biosciencesは売上高予測を以前の範囲である引き下げから$165M - $175Mに引き上げました。
Pacific Biosciencesは、14から1 9, 2023の間に8 5, 2026ガイダンスの更新を発表しました。During this period, the company raised its outlook 4 times and lowered it 9 times, providing investors with insight into management's evolving expectations.
Recent Earnings Results
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.14 | $-0.16 | $-0.15 |
| Actual | $-0.14 | $-0.12 | $-0.12 | $-0.12 |
| Surprise | -7.69% | +14.3% | +25.0% | +20.0% |
| Revenue | ||||
| Estimate | $41.0M | $40.2M | $41.8M | $40.1M |
| Actual | $39.0M | $37.2M | $44.6M | $38.4M |
| Surprise | -4.79% | -7.48% | +6.73% | -4.10% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.13 | $-0.12 | $-0.13 |
| Revenue | ||||
| Consensus | $39.3M | $42.9M | — | — |
Earnings & Guidance News
Benzinga
© 2026 Benzinga | All Rights Reserved